Cover Image
Market Research Report
Product code 
1064773

Attention Deficit Hyperactivity Disorder Drug Market 2021-2027

Published: | Orion Market Research Pvt Ltd | 121 Pages | Delivery time: 2-3 business days

Price

Back to Top
Attention Deficit Hyperactivity Disorder Drug Market 2021-2027
Published: February 1, 2022
Orion Market Research Pvt Ltd
Content info: 121 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

Global Attention deficit hyperactivity disorder drug market Size, Share & Trends Analysis Report By Drug Type (Stimulants, Non-stimulants), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, e-Commerce) by Age Group (Children and Adults), and Forecast (2020-2026)

The global attention deficit hyperactivity disorder drug market is anticipated to grow at a considerable CAGR during the forecast period. The increase in the number of pre-term deliveries of newborns is contributing the growth of the global attention deficit hyperactivity disorder drug market. According to the University of Maryland Medical Center (UMMC), this disease affects 20% of prematurely born babies currently. Governments across the globe are paying attention to the growing number of people suffering from a number of psychological disorders, including attention deficit hyperactivity disorder (ADHD). This focus of government towards treatment of such disease is further likely to drive the global market.

The global attention deficit hyperactivity disorder drug market is segmented based on drug type, distribution channel, and age group. Based on drug type, the attention deficit hyperactivity disorder drug market is segmented into stimulants and non- stimulants. Based on distribution channel, the attention deficit hyperactivity disorder drug market is segmented into hospital pharmacies, retail pharmacies, and e-commerce. Based on age group, the attention deficit hyperactivity disorder drug market is segmented into children and adults.

Geographically, the global attention deficit hyperactivity disorder drug market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global attention deficit hyperactivity disorder drug market include Pfizer Inc., Eli Lilly and Company., Novartis AG., GlaxoSmithKline PLC., Mallinckrodt Pharmaceuticals., Hisamitsu Pharmaceutical Co., Inc., and Johnson & Johnson., among others.

Market Segmentation

1. Global Attention Deficit Hyperactivity Disorder Drug Market Research and Analysis by Drug Type

2. Global Attention Deficit Hyperactivity Disorder Drug Market Research and Analysis by Age Group

3. Global Attention Deficit Hyperactivity Disorder Drug Market Research and Analysis by Distribution Channel

The Report Covers

  • Comprehensive research methodology of the global attention deficit hyperactivity disorder drug market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global attention deficit hyperactivity disorder drug market.
  • Insights about market determinants that are stimulating the global attention deficit hyperactivity disorder drug market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Product Code: OMR2024267

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Market Determinants

  • 3.1. Motivators
  • 3.2. Restraints
  • 3.3. Opportunities

4. Market Segmentation

  • 4.1. Global Attention Deficit Hyperactivity Disorder Drug Market by Drug Type
    • 4.1.1. Stimulants
    • 4.1.2. Non-Stimulants
  • 4.2. Global Attention Deficit Hyperactivity Disorder Drug Market by Age Group
    • 4.2.1. Children
    • 4.2.2. Adults
  • 4.3. Global Attention Deficit Hyperactivity Disorder Drug Market by Distribution Channel
    • 4.3.1. Hospital Pharmacies
    • 4.3.2. Retail Pharmacies
    • 4.3.3. E-Commerce

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Eli Lily & Company
  • 6.2. Johnson & Johnson Services, LLC
  • 6.3. Lupin Ltd.
  • 6.4. Mallinckrodt
  • 6.5. NEOS Therapeutics Inc.
  • 6.6. Novartis AG
  • 6.7. Pfizer Inc.
  • 6.8. Prude Pharma L.P.
  • 6.9. Shire

LIST OF TABLES

  • 1. GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2020-2027 ($ MILLION)
  • 2. GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER STIMULANTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER NON-STIMULANTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET RESEARCH AND ANALYSIS BY AGE GROUP, 2020-2027 ($ MILLION)
  • 5. GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG FOR CHILDREN MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG FOR ADULTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
  • 8. GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG FOR HOSPITAL PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG FOR RETAIL PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG FOR E-COMMERCE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 12. NORTH AMERICAN ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 13. NORTH AMERICAN ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2020-2027 ($ MILLION)
  • 14. NORTH AMERICAN ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET RESEARCH AND ANALYSIS BY AGE GROUP, 2020-2027 ($ MILLION)
  • 15. NORTH AMERICAN ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
  • 16. EUROPEAN ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 17. EUROPEAN ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2020-2027 ($ MILLION)
  • 18. EUROPEAN ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET RESEARCH AND ANALYSIS BY AGE GROUP, 2020-2027 ($ MILLION)
  • 19. EUROPEAN ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
  • 20. ASIA-PACIFIC ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 21. ASIA-PACIFIC ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2020-2027 ($ MILLION)
  • 22. ASIA-PACIFIC ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET RESEARCH AND ANALYSIS BY AGE GROUP, 2020-2027 ($ MILLION)
  • 23. ASIA-PACIFIC ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
  • 24. REST OF THE WORLD ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2020-2027 ($ MILLION)
  • 25. REST OF THE WORLD ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET RESEARCH AND ANALYSIS BY AGE GROUP, 2020-2027 ($ MILLION)
  • 26. REST OF THE WORLD ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET SHARE BY DRUG TYPE, 2020 VS 2027 (%)
  • 2. GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET SHARE BY AGE GROUP, 2020 VS 2027 (%)
  • 3. GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET SHARE BY DISTRIBUTION CHANNEL, 2020 VS 2027 (%)
  • 4. GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 5. US ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 6. CANADA ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 7. UK ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 8. FRANCE ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 9. GERMANY ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 10. ITALY ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 11. SPAIN ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 12. REST OF EUROPE ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 13. INDIA ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. CHINA ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. JAPAN ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. REST OF ASIA-PACIFIC ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 17. REST OF THE WORLD ATTENTION DEFICIT HYPERACTIVITY DISORDER DRUG MARKET SIZE, 2020-2027 ($ MILLION)